STP-369

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSTP-369
Drug Alias NameSTP-369
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApoptosis regulator Bcl-X inhibitorsInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitorsRNA interference
TargetsApoptosis regulator Bcl-XInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsHead and Neck NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomics
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A